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The Effects of Heat-Killed Echinostomatid Parasites on Mice Treated with Dextran Sodium 
Sulfate (DSS) 
Natalie Gooder 
Abstract 
Objective:  Autoimmune diseases are chronic, incurable, and affect approximately 50 million 
Americans.  This is a strong need for better ways to treat autoimmune diseases.  Parasites and 
parasite proteins have been observed to protect mice from symptoms of induced colitis in mice 
treated with dextran sodium sulfate (DSS), a model for inflammatory bowel disease (IBD).  I 
hypothesize that non-living echinostomatid parasites, given during DSS treatment, can decrease 
intestinal inflammation and weight loss, providing a possible novel treatment for IBD.   
Methods:  A range of DSS concentrations (0.5%-3%) were delivered to female C57BL/6 mice in 
their drinking water in order to determine the concentration that induced colitis but not severe 
morbidity; 1% DSS was determined to be optimal.  Next, two groups of mice were administered 
1% DSS in their drinking water for the first six days of the nine-day experiment, while two groups 
received regular water throughout.  The mice in one of the DSS treatment groups and one of the 
water control groups were orally administered heat-killed metacercariae in PBS on the third day 
of the experiment, while the remaining mice were administered just PBS as a control treatment.  
Weight of the mice and intestinal distress were monitored, as was water and food consumption.  
At the end of the experiment, colon lengths were measured and splenic cytokines (IL-4, IFN-γ, IL-
10, and IL-2) were assessed by ELISA.   
Results:  Mice with DSS induced colitis that received the parasite treatment demonstrated more 
weight loss (p=0.01) and poorer intestinal distress (p=0.02) on the ninth day when compared to 
mice with DSS induced colitis that did not receive parasite treatment.  The spleens from mice 
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receiving DSS and parasite treatment showed lower levels of regulatory cytokine IL-2 than mice 
receiving DSS but not parasite treatment (p=0.013).  Additionally, mice treated with DSS 
consumed less food on average than untreated mice (p<0.0001). 
Conclusion:  In contrast to my hypothesis, I found that feeding mice heat-killed echinostomatid 
parasites during DSS treatment did not improve symptoms of colitis.  Future studies could be 
performed to determine if non living parasites can counteract symptoms of colitis, a possible 
novel treatment for patients with IBD.  
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1. Introduction 
 
1.1. IBD and the Hygiene Hypothesis 
The 20th century brought forth better sanitation, high quality water, vaccines, and 
antibiotics within industrialized countries, leading to a decline in microbial and parasitic 
infections (1,2,3).  However, the 20th century also ushered in asthma, allergies, and a host of 
autoimmune diseases that had been uncommon previously and remain so in less developed 
countries (2-4).  While genetics and viruses are likely to be involved in autoimmunity (for 
example, if one identical twin has type 1 diabetes, the other twin has a 30% greater chance of 
developing the disease (5)), the increase in these diseases within the last 50 years has been so 
rapid that environmental changes are strongly suggested (5,6). 
Epidemiologic data and animal experimentation suggest that the elimination of 
helminth parasites contributes to the increasing prevalence of some immune mediated diseases, 
including inflammatory bowel disease (IBD), type 1 diabetes (T1D), multiple sclerosis (MS), 
rheumatoid arthritis (RA), asthma, and food allergies (2).  IBD, including Crohn’s disease (CD), 
which affects both the distal ileum and colon, and ulcerative colitis (UC), which affects the colon 
only, is characterized by chronic intestinal inflammation and epithelial damage (1,2,5-9) and 
usually begins during the second or third decade of life (8).  IBD has been steadily increasing 
since the mid-20th century, making it a significant health problem within developed countries 
(1,2).  It is estimated that over 2 million people in the USA or Europe have IBD (2,8), which is a 3-
4-fold increase since 1950 (5).  In 2014, the CDC reported an incidence rate of anywhere 
between 3 and 20 cases of IBD per 100,000 individuals in the US (7).  
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The etiology of IBD is not certain and can vary between patients with UC or CD.  Because 
the colon and terminal ileum contain most of the intestinal flora (2), one hypothesis is that IBD 
can result from an uncontrolled immune response to the normal gut flora (1).  Another 
hypothesis is that IBD is caused by an increased production of autoantibodies towards goblet 
cells (10).  No known bacterial or viral infections have been linked to IBD, although genetics can 
play a role in predisposing patients (1,2,6-9).  Epidemiological studies show an inverse 
relationship between the frequency of helminth worm infections and IBD (1).  IBD is common in 
industrialized countries where human helminth infections are relatively sparse.  Likewise, IBD is 
uncommon in less developed areas of the world where helminth infections are endemic, such as 
tropical countries in Asia and Africa (Fig. 1) (8,9).   
The rarity of IBD in tropical countries cannot be explained based on genetics alone, as 
descendants of immigrants from other countries acquire the higher risk of IBD of the adopted 
developed country (9).  The hygiene hypothesis was initially proposed by Strachan for hay fever 
and is now proposed for several immunological disorders, including allergic diseases and 
asthma, cardiovascular diseases, T1D, MS, and IBD (1).  Hay fever was less frequent in children 
from larger families where exchange of infections was common, as well as children exposed to a 
farming environment, or certain food born or oral-fecal infections (3).  This led to the hypothesis 
that the stimulation of the immune system by microbes or microbial products protects from the 
development of inflammatory diseases, therefore a reduced exposure to infectious agents may 
explain the rise in allergic and autoimmune diseases (3) 
The hygiene hypothesis for IBD is supported by geographical distribution, as IBD is seen 
more frequently among patients with a higher socioeconomic status, associated with better 
sanitation, high-quality water, and better medical standards (1).  In contrast, countries with 
higher infant mortality rates have lower reported incidence of IBD (1).  
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1.2. The Immune System 
The immune system is made up of both nonspecific (innate) and specific (adaptive) 
branches.  The innate immune system includes phagocytes, such as neutrophils and 
macrophages, dendritic cells, and cytotoxic cells like natural killer (NK) cells, which work to 
rapidly control a pathogenic invasion (1,9).  Adaptive immune cells, known as B and T 
lymphocytes, are antigen specific (1).  Antigens are taken up by antigen presenting cells (APCs) 
 
Fig. 1.  Global data shows an inverse correlation of IBD and helminth infections.  (A) 2012 prevalence 
of Schistosoma trematode infections (https://www.infectionlandscapes.org).  (B) 2015 incidence of 
IBD (https://oncofertility.northwestern.edu). 
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expressing MHC classes, such as dendritic cells and macrophages (1).  APC’s present fragments 
of the antigen to T cells, and function to release cytokines, or signaling proteins, and direct naïve 
T cells to differentiate into T helper cells (TH1, TH2) or regulatory T cells (TREG) (1,4,9).  B cells can 
recognize free antigens and can serve as APCs, leading to optimal antigen-specific CD4+ T cell 
expansion (1).  They can also differentiate into plasma cells that produce antibodies (IgG, IgA, 
IgM, IgE, IgD), which fight infection by tagging pathogens for destruction by phagocytes and 
other effector cells (4,11).  Adaptive immune responses are initially slow but improve on 
repeated exposure to a given antigen by the formation of B and T memory cells (1).   
  The balance between activating and inhibitory subsets of immune cells is important for 
the immune system to work optimally (11,12).  This is most clearly understood for T cells, in 
which effector T cells and regulatory T cells have opposing roles in maintaining this balance 
(11,12).  CD4+ TH1 cells secrete proinflammatory cytokines IFN-γ and IL-12 (Fig. 2), which 
enhance macrophage activity and promote the production of IgG during a normal immune 
response (1,9,10,13).  These cytokines are also associated with autoimmune diseases such IBD, 
T1D, RA, and MS (1-3,5-8,11-20).  TH1 cells additionally secrete IL-2, which is important for the 
proliferation of T cells, and research suggests that IL-2 specifically induces TREG cells and is an 
important regulator of autoimmunity (1,21).  CD4+ TH2 cells secrete IL-4, IL-5, IL-9, and IL-13 (Fig. 
2) which promote B cell production of IgE and signal the release of granules within basophils and 
eosinophils (1,9,10,13).  Basophils contain histamines within their granules and are associated 
with allergies, whereas eosinophils are often associated with helminth infections (1,20).  
Additionally, TH2 cells can secrete IL-10, a cytokine with well-known anti-inflammatory and 
immunosuppressive properties (10).  IL-10 blocks inflammatory cytokine production by T cells, 
NK cells, and macrophages, and can also induce T cell anergy (a state of immune 
unresponsiveness) in self-reactive T cells (10). 
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TH1 and TH2 cells cross 
regulate one another (9).  IFN-γ 
secreted by TH1 cells directly 
suppresses IL-4 production and 
inhibits the differentiation of 
naïve T cells into TH2 cells, 
whereas IL-4 and IL-10 inhibit the 
secretion of IL-12 and IFN-γ, 
blocking polarization into TH1 cells 
(9). T cells isolated from the 
colons of patients suffering from 
Crohn’s disease produce large 
amounts of IFN-γ and little IL-4 or 
IL-10 (9).  Shifting the paradigm of a TH1 cytokine-rich environment towards a TH2 polarized 
environment was proposed as a mode of therapy for autoimmune diseases including IBD (21), 
since chronic inflammation within the GI tract is TH1 mediated (2,5,6,8,9,15,16,22).   
The murine gut also harbors large numbers of Foxp3 CD4+ TREG cells, which function to 
restrain the host immune response to the normal intestinal flora (2).  TREG cells release IL-10 and 
TGF-β (Fig. 2) and regulate the immune system by inhibiting pro-inflammatory cytokine 
production (2,4,11).  B regulatory cells (BREG) are also a source of IL-10 and control intestinal 
inflammation by decreasing IFN-γ levels (11,12).  Furthermore, once stimulated BREG cells 
continue to produce IL-10, leading to long term regulation of the immune system (11).   
 
 
Fig. 2.  Overview of T cell subsets and cytokine production.  TH1 
specific cytokines IFN-γ and IL-12 cycle between immune cells 
and induce inflammatory responses.  TH2 specific cytokines IL-4, 
IL-5, IL-9, and IL-13 are triggered by allergic or parasitic 
infections and release granules in eosinophils or basophils.  TH2 
cells can also be a source of regulatory cytokine IL-10.  TREG cells 
function to regulate immune responses by producing IL-10 and 
TGF-β, which block cytokine production of other T cells subsets.  
Additionally, TH1 cells produce IL-2 which stimulates TREG cell 
production.  *Indicates cytokines analyzed in this study   
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1.3. Helminth Parasites and IBD 
Helminth parasites colonize more than one third of the world population and human 
infections are common within developing countries (1).  For chronic infection to occur, the 
parasite must first avoid clearance by the host immune system by altering mucosal and systemic 
immunity and inhibiting inflammatory responses (8).  The exact mechanism for this is unknown 
and can vary between different autoimmune diseases and different animal models.  During the 
acute phase of a parasitic infection, a TH2 response is initiated within the host (19), leading to IL-
4, IL-10, and IgE production and the release of granules within eosinophils (9,10).  A shift from 
TH1 to TH2 profiles in hosts was initially used to explain evidence that helminth parasites protect 
from autoimmune disease but does not explain the rise in allergies within developed countries, 
which are TH2 dependent (1-3,5,7,14). 
Helminths can also protect from allergic reactions within a host, suggesting that 
additional mechanisms of regulation must occur that are independent of TH2 cytokines (2).  It is 
suggested that during the chronic phase of infection, helminths produce several products with 
immune modulatory properties including molecules that induce TREG cells and inhibit the 
effector function of self-reactive T cells (2,19).  However, other studies suggest that parasite 
induced protection of IBD can inhibit TH1 proliferation without the need for IL-10 or TGF-β (2).  
In one study it was demonstrated that helminth infections in IL-10 deficient mice still prevent 
colitis (2).  It has also been shown that regulatory dendritic cells and alternatively activated 
macrophages (M2) inhibit T effector cell function in a manner independent of TREG cells, IL-10 
and TGF-β (2).  Also, because intestinal helminths must breach the mucosal barrier to reach the 
immune system it has been suggested that direct interactions between intestinal helminths and 
the gut epithelium may play a role in regulating symptoms of IBD (2).  
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1.4. Effect of Parasites on Colitis  
The effects of helminth parasites on autoimmune diseases have been tested in multiple 
studies within the last 20 years, confirming that parasites can protect from chronic inflammation 
(1-5,7,9,12,13,15-20,23).  IBD is characterized by intestinal inflammation and epithelial damage, 
and includes symptoms of bloody diarrhea, pain, fatigue, and weight loss (6-9,14,16,20,22).  
Chemical-induced colitis models, including trinitrobenzene sulfonic acid (TNBS), and dextran 
sulfate sodium (DSS) are widely used in research studies and closely mimic the symptoms of 
human IBD (9,16,20,22-24).  DSS induces colitis in mice by forming nano-lipocomplexes with 
medium-chain-length fatty acids in the colon (24).  The DSS-induced colitis model has been 
shown to induce changes in TH1/TH2 cytokine profiles, leading to an increase in pro-
inflammatory cytokines (8,16,20).   
Elliott et al. proposed the hypothesis that the loss of exposure to parasitic worms 
increased the risk of IBD and illustrated a protective response of Schistosoma mansoni infection 
on TNBS-induced colitis is mice (1).  Schistosoma mansoni is a water-borne blood fluke that 
infects human blood vessels near the intestinal tract, causing intestinal schistosomiasis (14,20).  
Schistosomes undergo their intermediate life cycle by infecting snails, then adult larvae can 
penetrate through the skin of humans (20).  Clinical symptoms develop when schistosome eggs 
migrate through intestinal tissue (20).  Smith et al. demonstrated a protective response of S. 
mansoni worms on DSS-induced colitis in BALB/c mice, showing that mice subcutaneously 
infected with male cercariae and treated with 5% DSS 7-8 weeks post infection had significantly 
reduced intestinal distress indicated by less weight loss, lower intestinal scores, and longer colon 
lengths after dissection then uninfected mice (20).  Infection of BALB/c mice with S. mansoni 
was shown to protect mice from symptoms of colitis through the induction of M2 macrophages, 
independent of TREG cells, IL-10, and TGF-β (2).  Smith et al. further demonstrated that S. 
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mansoni eggs do not induce protection from DSS-induced colitis in BALB/c mice by 
subcutaneously infecting mice with both male and female cercariae and treating with DSS 4 
weeks after egg laying had commenced (20).  Mice developed more severe colitis when infected 
with S. mansoni eggs then uninfected mice, suggesting that protection from colitis is only 
achieved through the adult larvae cycle of S. mansoni (20).   
In response to overwhelming evidence that helminth parasite infections protect from 
induced colitis in mice, Summers and Weinstock et al. performed a series of clinical studies, 
treating IBD patients with Trichuris suis eggs (1,2,8).  Trichuris suis is an intestinal whipworm 
commonly found in pigs (8,14.).  T. suis does not require an intermediate host; its eggs are 
passed in feces from infected animals and its juvenile larvae can directly penetrate the mucosa 
of the intestines (14).  While T. suis is not a human parasite, its juvenile worms can colonize a 
human host for several weeks and are eliminated thereafter without any specific therapy (8).  If 
clinical symptoms occur in humans, they are mild and treatable (8,14).  In these studies, 29 
patients with long standing Crohn’s Disease, and 45 patients with Ulcerative Colitis were orally 
infected with Trichuris suis eggs (1,2,8).  After 24 weeks, 21 patients with CD were in remission, 
and another two had improved symptoms (2,8).  Additionally, about 50% of patients with UC 
reported improved symptoms (1,8).   
The use of living infectious parasites may not be necessary for treating patients with 
autoimmune disease.  It has been shown that excretory/secretory products of Fasciola hepatica 
parasites, collected after culturing them in vitro, exert a potent immune-modulatory effect in 
BALB/c and C57BL/6 mice by activated regulatory M2 macrophages, suppressing dendritic cell 
maturation, and inhibiting TH1 cell differentiation (13,19).  Another study delivered a single 
recombinant parasite protein, galectin, isolated from the Toxascaris leonine nematode to 
C57BL/6 mice prior to treatment with DSS (16).  Galectins are highly conserved animal lectins 
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with an affinity for β-galactose containing oligosaccharides (16,25), and have been shown to 
affect different functions relevant to innate and adaptive immunity (16).  Previous studies have 
suggested that galectin-8 may play a suppressive role in IBD and RA.  Mice injected with 
galectin-8 (rTI-GAL) before treatment with DSS demonstrated less weight loss, lower intestinal 
scores, longer colons after dissection, lower levels of IFN-γ and IL-4, and higher levels of IL-10 
and TGF-β compared to mice not injected with rTI-GAL before DSS treatment (16).   
In previous studies of parasites on mice models of colitis, the subcutaneous infection 
with a parasite, or the injection of a parasite protein was delivered before treatment with DSS, 
as a prevention method of DSS-induced colitis (Fig. 3) (9,16,20).  It is currently unknown whether 
administering parasites or parasite products during treatment with DSS can also decrease 
symptoms of induced colitis in mice.  Also, because a 
parasite protein is enough to protect mice from DSS-
induced colitis (16), we questioned whether feeding 
mice non-living whole parasites could also decrease 
symptoms of induced colitis.  This study addresses 
whether feeding C57BL/6 mice whole, heat-killed 
parasites after several days of DSS treatment will 
decrease symptoms of DSS-induced intestinal 
damage, resulting in less weight loss, improved 
intestinal health, and longer colon lengths after 
dissection, and whether a decrease in symptoms is 
accompanied by a shift in TH1 cytokines to TH2 and 
TREG cytokines.  
 
Fig 3.  Parasites or recombinant parasite 
proteins (galectin) have been shown to protect 
from DSS-induced colitis in mice when mice 
are infected with cercariae or injected with 
galectin prior to treatment with DSS.      
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1.5. Rationale and Hypothesis 
Echinostomatids are a family of intestinal parasites from the class Trematoda 
(flatworms) and can cause disease in mammals and birds (1,14,26).  Typically, the life cycle of 
echinostomatids includes three different hosts: an invertebrate first intermediate host, typically 
a mollusk, a second intermediate host carrying the encysted metacercarial stage, and a 
vertebrate definitive host (26).  Echinostome metacercariae can be obtained locally from 
infected snails.  Here, we test the effects of feeding heat-killed echinostome metacercariae to 
C57BL/6 mice after three days of DSS treatment.  We hypothesize that C57BL/6 mice treated 
with DSS for 6 days and administered heat-killed metacercariae during DSS treatment will show 
less weight loss, improved intestinal health, and longer colon lengths after dissection than mice 
treated with DSS but not administered metacercariae.  Furthermore, we hypothesize that a 
decrease in symptoms can be linked to a decrease in inflammatory cytokines IFN-γ and IL-4, 
and/or an increase in regulatory cytokines IL-10 and IL-2.   
 
1.6 Summary 
Research described in this thesis demonstrates that 3%, 2.25%, or 1.5% DSS dissolved in 
drinking water for 6 days causes loose stools that are highly bloody and/or weight loss of over 
25% of the initial body weight, whereas 1% DSS causes loose stools and weight loss of less than 
25% of the initial body weight, and 0.5% DSS does not cause significant intestinal distress.  
Furthermore, mice treated with 3%, 2.25%, 1.5%, or 1% DSS drink less water on average than 
untreated mice.  Mice treated with 1% DSS for 6 days and administered heat-killed echinostome 
metacercariae during DSS treatment do not show less weight loss, improved intestinal health, or 
longer colons after dissection when compared to mice treated with 1% DSS and administered 
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PBS.  Inversely, mice administered metacercariae during DSS treatment show more weight loss 
and higher intestinal scores on the ninth day.  However, mice administered PBS and treated with 
1% DSS lose less weight than mice treated with 1% DSS in the initial trial, and mice administered 
PBS and given regular water gain less weight than control mice in the initial trial.  Analysis of 
splenic cytokines show a decrease in regulatory cytokine IL-2 levels in mice treated with DSS and 
administered metacercariae when compared to mice in all other groups.  Furthermore, mice 
treated with 1% DSS consume less food then untreated mice.   
We conclude that heat-killed metacercariae fed orally to C57BL/6 mice after several 
days of DSS treatment do not decrease symptoms of DSS-induced colitis but may exacerbate 
symptoms.  Because previous studies provided an ongoing parasite stimulus to protect from 
immune mediated symptoms (1,2,9,13,16,18,20), we question whether delivering multiple 
doses of metacercariae during DSS treatment could decrease symptoms of induced colitis.  We 
also question whether gavaging mice or administering PBS orally affects water consumption and 
therefore weight loss.  Further studies may be necessary to determine whether nonliving whole 
parasites can be used as a form of treatment for models of IBD or other autoimmune diseases. 
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2. Methods 
 
2.1. DSS-induced model of colitis  
It has been previously shown that mice models of colitis can be established in C57BL/6 
mice by dissolving small amounts of dextran sodium sulfate (DSS) salt into drinking water 
(16,20,23,24).  An optimal DSS dosage is needed to test the effects of heat-killed parasite 
treatment on mediating DSS-induced colitis to model the autoimmune disorder, inflammatory 
bowel disease (IBD).  Many factors affect DSS-induced colitis, including mouse age, gender, 
strain, and environmental conditions of vivarium (23), therefore a range of DSS doses were 
tested.  An optimal dosage will result in the slow and steady onset of symptoms, and the mice 
will remain healthy enough to last throughout the experimental period (23).   
  Since the effects of DSS can be variable, five mice were included per group.  Three 
groups were given different DSS (36-50,000 M. Wt., MP Biomedicals) concentrations dissolved in 
drinking water with a fourth group used as a control.  Initially, a range of 1.5%-3% DSS was 
tested, then the experiment was repeated using 0.5%-1.5% DSS.  Prior to each 9-day 
experiment, mice were sedated using a mixture of 4% isoflurane gas with 1% oxygen and 
identified with ear tags, then assigned to random groups (randomlists.com/team-generator).  
On Day 0, the mice were weighed, and the groups adjusted so that each group had a similar 
average weight (Tables 1 and 2).  Mice in each group were divided into two cages to prevent 
overcrowding.  To minimize cage variance, each treatment group had one cage with two mice 
and one cage with three mice.  DSS treatment was given on days 0-5, and regular water on days 
6-9.   
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The control group was given regular water throughout the experiment.  DSS solutions/water 
were changed every two days with the remaining volume recorded and divided by the number 
of mice per cage to determine average water consumption.    
At approximately the same time each day, mice were individually weighed and placed in 
an empty cage to allow for stool collection.  Stool consistency was recorded, and two different 
areas of the stool were smeared on a hema-screenTM card (Immunostics) to detect for fecal 
blood.   Hema-screen cards contain the compound guaiac (alpha-guaiaconic acid), which is 
Table 1.  Mice ID numbers and initial weight for 
Experiment 1. 
 
Amount of 
DSS 
Age on Day 
0 
Mice ID Weight (g) 
Amount 
of DSS 
Age on Day 
0 
Mice ID Weight (g) 
 7 w, 1 d 913 16.92  7 w, 3 d 32 17.69 
 7 w, 1 d 915 15.87  7 w, 3 d 29 17.62 
1.5% DSS 6 w, 6 d 919 17.64 0.5% DSS 8 w 14 17.85 
 6 w, 6 d 933 15.76  8 w 17 17.44 
 6 w, 6 d 921 18.17  7 w, 3 d 34 17.48 
    Average= 16.87     Average= 17.62 
 7 w, 7 d 910 18.46  7 w, 3 d 33 18.85 
 6 w, 6 d 925 16.4  6 w, 6 d 23 18.72 
2.25% DSS 7 w, 1 d 912 15.75 1% DSS 8 w 15 18.57 
 7 w, 1 d 918 16.93  6 w, 6 d 21 18.03 
 6 w, 5 d 928 16.92  6 w, 2 d 31 13.84 
    Average= 16.89     Average= 17.6 
 7 w, 1 d 917 17.17  6 w, 6 d 22 18.12 
 7 w, 7 d 911 18.58  6 w, 6 d 25 18.14 
3% DSS 7 w, 1 d 916 15.5 1.5% DSS 8 w 13 18.25 
 6 w, 6 d 923 17.76  6 w, 3 d 47 16.86 
 6 w, 6 d 924 17.42  6 w, 5 d 36 16.78 
    Average= 17.29     Average= 17.63 
 6 w, 6 d 920 17.3  6 w, 5 d 35 17.11 
 6 w, 4 d 929 18.04  6 w, 6 d 24 19.18 
0% DSS 6 w, 6 d 927 16.7 0% DSS 6 w, 3 d 45 15.46 
 6 w 930 17.4  8 w 19 17.68 
 6 w 932 15  8 w 18 18.36 
  Average= 16.89   Average= 17.56 
 
Table 2.  Mice ID numbers and initial weight for 
Experiment 2. 
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oxidized by hemoglobin, resulting in a dark blue color within 30 seconds in the presence of 
blood.  For the initial experiment, stools were rated on a scale of 0-4 for stool consistency and 
presence of fecal blood (0=Normal stool, -blood; 1=normal stool, +blood, or soft stool, -blood; 
2=soft stool, +blood, or loose stool, -blood; 3=loose stool, + blood, or diarrhea, -blood; 
4=diarrhea, +blood) (Table 3).  For the second experiment, visible blood in stools was included 
as a factor (4=loose bloody stool, +blood; 5=bloody diarrhea, +blood) (Table 4). 
At the beginning of each experiment, a humane handling weight (75% of weight on Day 
0) was calculated for all mice and if any mice reached that body weight prior to the end of the 
experiment they were euthanized by CO2 gas to minimize extreme suffering.  At the end of each 
experiment, all remaining mice were euthanized by CO2 gas.  
 
2.2.     Counteraction of DSS-induced intestinal distress with Echinostomatid parasites 
It has been previously shown that overexpression of the parasite protein galectin in 
mice models of IBD protects the mice from developing intestinal distress by inducing a large TREG 
Intestinal 
Score 
Visible Stool 
Consistency 
Presence of 
Blood as 
determined by 
hema-screen 
0 Normal - 
1 Normal + 
1 Soft - 
2 Soft + 
2 Loose - 
3 Loose + 
3 Diarrhea - 
4 Diarrhea + 
 
Table 3.  Intestinal Scores for Experiments 1 and 3 
Intestinal 
Score 
Visible Stool 
Consistency 
Presence of 
Blood as 
determined by 
hema-screen 
0 Normal - 
1 Normal + 
1 Soft - 
2 Soft + 
2 Loose - 
3 Loose + 
3 Diarrhea - 
4 Loose, bloody + 
4 Diarrhea + 
5 Diarrhea, bloody + 
   
 
Table 4.  Intestinal Scores for Experiment 2 
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population (16).  The effects of heat-killed echinostome metacercariae were tested in an 
attempt to counteract the symptoms of DSS-induced intestinal distress (Fig. 4).  As with the 
previous tests, female C57BL/6 mice were used, but with eight mice per group to enable 
detection of modest changes.  Four groups were included to properly test all variables (DSS + 
Parasites, Water + Parasites, DSS + PBS, and Water + PBS).  Mice were identified and assigned 
groups as described in section 2.1 (Table 5).  1% DSS treatment was given to mice in Groups 1 
and 3 on days 0-5, and regular water on days 6-9.  Regular water was given to mice in Groups 2 
and 4 for all 9 days.  Mice weight, stool consistency, and presence of fecal blood were recorded 
daily.  DSS solutions/water were changed every two days with the remaining volume used to 
determine average water consumption.  Food was also weighed every two days and used to 
determine average food consumption in the same method as water consumption.      
Echinostome metacercariae were isolated from infected Lymnaea snails that were 
obtained through Dr. Sorensen (MSU, Mankato).  The infected snails were dissected and 
metacercariae were isolated and counted using a dissecting microscope and divided between 16 
tubes (approximately 30-40 metacercaria per tube).  Metacercariae were stored at room 
temperature for 2-3 days in a salt solution (Lockes).  On the day before administration to mice, 
metacercariae were washed twice with PBS (phosphate-buffered saline).  PBS was then added 
to a total volume of 200 μL to all tubes placed in a thermocycler (Prime, TECHNE) at 72°C for 15 
 
Fig 4.  Timeline of Experiment 3: Administration of heat-killed Echinostomatid metacercariae 
to mice treated with 1% DSS.  DSS was dissolved in drinking water for 6 days followed by 
regular water for 3 days.  Metacercariae or PBS was orally delivered to mice on Day 3. 
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minutes followed by 95°C for 15 minutes to kill the metacercariae, as previously demonstrated 
in Hafalla et al. (27), and stored at 4°C overnight.  Before weight and stool measurements were 
collected on Day 3, metacercariae in PBS or 200 μL PBS was administered to mice using an 18-
gauge feeding tube 1.5 inches in length with a rounded tip.  Mice were held by the scruff of the 
neck and the gavage tube was placed in the diastema of the mouth and gently advanced along 
the upper palate until the esophagus was reached.  Once proper placement was verified, 
metacercariae in PBS or PBS was administered by a 1 cc syringe attached to the end of the 
feeding tube.  After dosing, the mice were returned to their cage and monitored for signs of 
labored breathing or distress for 5-10 minutes, and again after a few hours.  Feeding tubes and 
gavages were examined under the dissecting microscope to confirm that the metacercariae 
were no longer present.   
Table 5.  Mice ID numbers and initial weight for Experiment 3. 
 
Treatment 
Group 
Age on 
Day 0 
Mice ID 
Weight 
(g) 
Treatment 
Group 
Age on 
Day 0 
Mice ID 
Weight 
(g) 
 7 w, 2 d 232 16.7   7 w, 1 d  222 16.9 
 7 w, 2 d 225 17   7 w, 1 d 224 17.9 
 7 w, 4 d 243 16.65   7 w, 4 d 229 17.18 
 7 w, 4 d 245 14.4   7 w, 3 d 235 16.7 
DSS + Parasite 7 w, 4 d 248 15.8 DSS + PBS 7 w, 3 d 238 15.3 
 7 w, 5 d 252 16.68   7 w, 4 d 242 16.12 
 7 w, 5 d 254 18.16   7 w, 4 d 249 17.62 
 7 w, 5 d 256 18.97   7 w, 4 d 251 16.88 
    Average= 16.795     Average= 16.825 
 7 w, 4 d 233 15.92   7 w, 2 d 227 17.42 
 7 w, 3 d 226 17.58   7 w, 2 d 228 17.8 
 7 w, 3 d 236 17.75   7 w, 3 d 234 17.5 
 7 w, 3 d 237 16.5   7 w, 4 d 239 14.72 
Water + 
Parasite 
7 w, 4 d 240 15.85 Water + PBS 7 w, 4 d 250 17.93 
 7 w, 4 d 244 17.62   7 w, 5 d 253 16.16 
 7 w, 4 d 246 16.95   7 w, 5 d 255 16.52 
 7 w, 4 d 247 17.05   7 w, 5 d 257 17 
  Average= 16.9025    Average= 16.88125 
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After data collection on Day 9, all mice were euthanized by CO2 gas and dissected to 
harvest the spleens and intestines.  Spleens were placed into wells containing 1 mL sterile cold 
PBS and disrupted with the flat plunger end of a sterile syringe.  Cells suspensions were 
transferred to sterile microfuge tubes containing 1 ml PBS and 100 μL of 1.1% IGEPAL (Alfa 
Aesar) and kept on ice.  Cell suspensions were vortexed for 1 minute, then centrifuged for 5 
minutes at 8000 rpm.  Supernatants were transferred to new sterile microfuge tubes and stored 
at -20°C until analyzed for pro-inflammatory cytokines IFN-γ, parasite specific cytokine IL-4, and 
regulatory cytokines IL-10 and IL-2 presence, using enzyme-linked immunosorbent assay (ELISA).   
Intestines were placed into tubes containing 10 mL of 10% formalin and kept at 4°C for analysis 
of colon length.  To measure colon length, intestines were straightened and measured from the 
ileocecal junction to the rectum.   
 
2.3. Analysis of splenic cytokines IL-4, IFN-γ, IL-2, and IL-10 
Splenic supernatants were vortexed briefly and diluted twofold or tenfold with sterile 
PBS.  A Mouse TH1/TH2 Uncoated ELISA kit (ThermoFisher Scientific) was purchased.  The 
detection ranges given by the manufacturer for each cytokine were: IL-4, 4-500 pg/mL; IFN-γ, 
15-2000 pg/mL; IL-2, 2-200 pg/mL; and IL-10, 30-4000 pg/mL.  In all samples where the 
calculated cytokine concentration was at or below the given sensitivity, it was graphed as the 
lowest detectable level for that cytokine.  To analyze cytokine concentrations, ELISA plates were 
coated with 100 μL/well of IL-4, IFN-γ, IL-2, or IL-10 capture antibody in Coating Buffer then 
sealed and incubated overnight.  The following day wells were aspirated 3 times with Wash 
Buffer and blocked with 200 μL/well of ELISA/ELISASPOT diluent.  The plates were incubated at 
room temperature for 1 hour, then the wells were aspirated once with Wash Buffer.  Standards 
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were prepared according to the manufacturer’s instructions and diluted to make a 6-point 
standard curve (Fig. 5).  100 μL/well of standards or samples were added to appropriate wells.  
Three or four specimens per treatment group were included with two or three replicates per 
sample.  The plates were sealed and incubated overnight.  The following day, the wells were 
 
Fig. 5.  ELISA mouse TH1/TH2 standard curves used for cytokines IL-2, IL-4, IL-10, and IFN-γ.  
Standards were diluted according to manufacturer’s instructions and used to make a 6-point curve 
with two or three duplicates per sample. GraphPad Prism 7 was used to calculate standard curve 
equations and R2 values.  (A-B) TH1; TREG cytokine IL-2.  (C) TH2; parasite specific cytokine IL-4.  (D) 
TH2; TREG cytokine IL-10.  (E) TH1, pro-inflammatory cytokine IFN-γ. 
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aspirated 5 times with Wash Buffer then 100 μL/well of IL-4, IFN-y, IL-2, or IL-10 diluted 
detection antibody was added, and plates were sealed and incubated at room temperature for 1 
hour.  Wells were aspirated 5 times with Wash Buffer then 100 μL/well of diluted Avidin-HRP 
enzyme was added, and plates were sealed and incubated at room temperate for 30 minutes.  
Wells were aspirated 7 times with Wash Buffer then 100 μL/well of TMB (tetramethylbenzidine) 
substrate solution was added, and plates were incubated at room temperature for 15 minutes.  
50 μL/well of Stop Solution was added and plates were read at 450 nm in a MultiSkan Spectrum 
plate reader (ThermoFisher).  For IL-4, IFN-γ, and IL-10, one ELISA plate was analyzed (three or 
four specimens per treatment group), and for IL-2, two ELISA plates were analyzed (five or six 
specimens per treatment group).  For all plates, GraphPad Prism 7 was used to calculate 
standard curve equations and interpolate x-values.  X-values were multiplied by 2 or 10 
depending on the dilution factor to give cytokine concentrations.   
 
2.4. Statistical analysis 
 GraphPad Prism 7 software was used to perform all statistical testing.  For comparison 
of groups for weight change, intestinal score, food consumption, and water consumption, 
repeated measures, 2-way ANOVA matching: stacked with Tukey’s multiple comparisons test 
was performed.  For data sets with missing values, mixed-affects model: matching: stacked with 
Tukey’s multiple comparisons test was performed instead.  For comparison of groups for colon 
length, 1-way ANOVA with Tukey’s multiple comparisons test was performed.  For comparison 
of groups for IL-2 concentrations, 1-way ANOVA with Tukey’s multiple comparisons test, or 
unpaired t test with Welch’s correction was performed.  For all group comparisons, results were 
expressed as group means with standard deviations.  For cytokine concentrations, linear 
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regression was used to calculate standard curve equations and interpolate x values.  For 
comparison of individual data points, linear regression was used to calculate line equations, R2 
values, and p values.  P values of <0.05 were considered statistically significant for all tests.     
 
 
3. Results 
 
3.1. 3%, 2.25%, and 1.5% DSS administered through drinking water induces acute intestinal 
inflammation in C57BL/6 mice and causes excessive weight loss. 
The overall goal of this study was to test the effects of non-living parasites on mice 
models of IBD, by orally administering heat-killed metacercariae to mice treated with DSS.  
Therefore, an optimal concentration of DSS which causes weight loss and loose stools while 
allowing mice to survive the entire experiment (mice that lose >25% of their body weight must 
be euthanized for ethical purposes), was necessary for this study.   
An initial experiment was performed on 20 female, C57BL/6 mice, ages 6-8 weeks.  Five 
mice per treatment group were included.  Individual mice were given ear tags prior to the 
experiment and randomly assigned treatment groups.  Individual mice were then weighed, and 
treatments groups were adjusted slightly so that each group weighed approximately the same 
(Table 1).  DSS treatment cages were administered either 3%, 2.25%, or 1.5% DSS dissolved in 
drinking water for 6 days, followed by regular water for 3 days.  Control cages were 
administered regular water for all 9 days.  DSS solutions/water were replaced every two days 
and the remaining volume from each cage was recorded.  Average water consumption per 
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mouse was calculated by dividing the remaining volume from each cage by the number of mice 
(two or three) per cage.  Weight, stool consistency, and presence of fecal blood (hema-screen) 
were recorded daily for individual mice.  Stool consistency and presence of fecal blood were 
used to assign individual mice an intestinal score from 0-4 (Table 3).  If a mouse lost >25% of its 
body weight at any time during the experiment it was euthanized after data collection for that 
day.  At the end of 9 days, all remaining mice were euthanized.   
Over the course of treatment, the group receiving 3% DSS began testing positive for 
fecal blood on the first day and developed loose stools starting on the fourth day.  When 
compared to the control group, mice receiving 3% DSS had higher intestinal scores from the first 
to the seventh day, (p<0.0001, 2- way ANOVA) (Fig. 6A).  Mice receiving 3% DSS lost more 
weight than the control group from the fifth to the seventh day (p≤0.0002, 2-way ANOVA) (Fig. 
6B).  Two mice receiving 3% DSS lost over 25% of their body weight on the seventh day, and the 
remaining three mice on the eighth day (Table 6).  Mice receiving 3% DSS also consumed less 
water on the sixth day (p=0.055) and eighth day (p=0.0001, 2-way ANOVA) when compared to 
the control group (Fig. 6C).   
Similarly, the group receiving 2.25% DSS began testing positive for fecal blood on the 
first day and developed loose stools starting on the fourth day.  When compared to the control 
group, mice receiving 2.25% DSS had higher intestinal scores from the first to the seventh day 
(p<0.0001, 2-way ANOVA) (Fig. 6A).  Mice receiving 2.25% DSS also lost more weight than the 
control group from the fifth to the seventh day (p<0.001, 2-way ANOVA) (Fig. 6B).  Four mice 
receiving 2.25% DSS lost over 25% of their body weight on the eighth day, and the remaining 
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one mouse on the ninth day (Table 6).  Mice receiving 2.25% DSS also consumed less water on 
the eighth day when compared to the control group (p=0.0008, 2-way ANOVA) (Fig. 6C).   
The group receiving 1.5% DSS began testing positive for fecal blood on the second day 
and developed loose stools starting on the fifth day.  When compared to the control group, mice 
receiving 1.5% DSS had higher intestinal scores from the second to the seventh day (p<0.0005, 
2-way ANOVA) (Fig. 6A).  A linear equation was calculated for intestinal score from the fourth to 
sixth day, when intestinal distress increased significantly (y=0.85x-1.383, linear regression) 
(Appendix 1A).  Mice receiving 1.5% DSS also lost more weight than the control group from the 
 
Fig. 6.  3%, 2.25%, or 1.5% DSS induces acute intestinal distress in C57BL/6 mice but causes excessive weight 
loss.  3%, 2.25%, or 1.5% DSS was dissolved in drinking water and administered to mice for 6 days, followed by 
regular water for 3 days.  Control mice were administered regular water for all 9 days.  Five mice per 
treatment group were included.  For all panels, group means, and standard deviations are plotted.  (A) Stool 
consistency and presence of fecal blood (hema-screen) were used to provide mice an intestinal score of 0-4.  
(B) Weight change during treatment, expressed as a percentage change from day 0.  (C) Average water 
consumption per mouse was calculated by dividing the remaining volume in cages every two days by the 
number of mice per cage.  Statistical differences of groups (p<0.05) was determined using RM 2-way ANOVA, 
matching: stacked with Tukey’s multiple comparisons. 
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fifth to the seventh day (p≤0.0012, 2-
way ANOVA) (Fig. 6B).  One mouse 
receiving 1.5% DSS lost over 25% of 
their body weight on the seventh day, 
an additional one mouse on the eighth 
day, and the remaining two mice on 
the ninth day (Table 6).  Mice receiving 
1.5% DSS also consumed less water on the eighth day when compared to the control group 
(p=0.0005, 2-way ANOVA) (Fig. 6C). 
 
3.2. 1% DSS administered through drinking water induces acute intestinal inflammation in 
C57BL/6 mice without causing excessive weight loss or highly bloody stools. 
Because the first tested range of 1.5%-3% DSS did not reveal an optimal model of IBD 
(no differences between DSS groups were demonstrated for weight loss or intestinal scores, and 
most mice in all DSS treatment groups lost >25% of their body weight before day 9), the 
experiment was repeated using a lower range of 0.5%-1.5% DSS.  Twenty female C57BL/6 mice, 
ages 6-8 weeks were identified and assigned treatment groups using the same method as the 
first experiment.  Five mice per treatment group were included (Table 2).  DSS treatment cages 
were administered either 1.5%, 1%, or 0.5% DSS dissolved in drinking water for 6 days, followed 
by regular water for 3 days.  Control cages were administered regular water for all 9 days.  DSS 
solutions/water were replaced every two days and average water consumption per mouse was 
calculated as previously described.  Weight, stool consistency, and presence of fecal blood 
(hema-screen) were recorded daily for individual mice.  Mice were assigned an intestinal score 
Treatment 
Group (n=5) 
# of mice that lost >25% body weight 
  Days 1-6 Day 7 Day 8 Day 9 
Control 0 0 0 0 
1.5% DSS 0 1 2 2 
2.25% DSS 0 0 4 1 
3% DSS 0 2 3 N/A 
 
Table 6.  Number of mice that lost over 25% of their initial 
body weight on each day during Experiment 1. 
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from 0-5 as previously described, but with the addition of visible blood in stools as a factor 
(Table 4).  If a mouse lost >25% of its body weight at any time during the experiment, it was 
euthanized after data collection for that day.  At the end of 9 days, all remaining mice were 
euthanized. 
Similar to the first experiment, mice receiving 1.5% DSS began testing positive for fecal 
blood on the second day and developed loose stools starting on the fifth day.  Mice receiving 
1.5% DSS had higher intestinal scores than control mice from the second to the eighth day 
(p≤0.05), and higher scores than mice receiving 0.5% DSS from the fifth to the eighth day 
(p<0.0037, mixed-affects model) (Fig. 7A).  A linear equation was calculated for intestinal score 
from the fourth to sixth day, when intestinal distress increases significantly (y=1.55x-4.483, 
linear regression) (Appendix 1B).  Mice receiving 1.5% DSS lost more weight than control mice 
from the fifth to the eighth day (p≤0.0019), and lost more weight than mice receiving 0.5% from 
the sixth to the eighth day (p<0.0001, 2-way ANOVA) (Fig. 7B).   
Additionally, mice receiving 1.5% DSS had higher intestinal scores than mice receiving 
1% DSS on the sixth day (p=0.0266, mixed model analysis), and lost more weight than mice 
receiving 1% DSS on the seventh and eighth days (p≤0.0026, 2-way ANOVA).  All five mice 
receiving 1.5% DSS lost over 25% of their body weight on the eighth day (Table 7).  Also, mice 
receiving 1.5% DSS consumed less water than control mice and mice receiving 0.5% DSS on the 
eighth day (p≤0.002, 2-way ANOVA) (Fig. 7C). 
Similarly, the group receiving 1% DSS began testing positive for fecal blood on the 
second day and developed loose stools starting on the fifth day.  Mice receiving 1% DSS had 
higher intestinal scores than control mice on the fourth to the the eighth day (p≤0.05) and 
higher scores than mice receiving 0.5% DSS from the sixth to the eighth day (p≤0.0056, mixed-
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model analysis) (Fig. 7A).  A linear equation was calculated for intestinal score from the fourth to 
sixth day (y=0.968x-2.128, linear regression) (Appendix 1C).  Mice receiving 1% DSS lost more 
weight than control mice and mice receiving 0.5% DSS from the sixth to the eighth day 
(p<0.0001, 2-way ANOVA) (Fig. 7B).   
One mouse receiving 1% DSS lost over 25% of their body weight on the eighth day, and 
two additional mice on the ninth day (Table 7).  Also, mice receiving 1% DSS consumed less 
water than control mice and mice receiving 0.5% DSS on the eighth day (p≤0.0235, 2-way 
ANOVA) (Fig. 7C).   
 
Fig. 7.  1% DSS induces acute intestinal distress in C57BL/6 mice without causing excessive weight loss or 
highly bloody stools.  1.5%, 1%, or 0.5% DSS was dissolved in drinking water and administered to mice for 6 
days, followed by regular water for 3 days.  Control mice were administered regular water for all 9 days.  
Five mice per treatment group were included.  For all panels, group means, and standard deviations are 
plotted.  (A) Stool consistency and presence of fecal blood (hema-screen) were used to provide mice an 
intestinal score of 0-5.  (B) Weight change during treatment, expressed as a percentage change from day 0.  
(C) Average water consumption per mouse was calculated by dividing the remaining volume in cages every 
two days by the number of mice per cage.  Statistical differences of groups (p<0.05) was determined using 
RM 2-way ANOVA or mixed-affects model, matching: stacked with Tukey’s multiple comparisons. 
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The group receiving 0.5% DSS 
began testing positive for fecal blood 
on the second day but did not 
develop loose stools throughout the 
experiment.  Mice receiving 0.5% DSS 
did not had higher intestinal scores 
or lose more weight than control 
mice throughout the experiment.  Mice receiving 0.5% DSS also did not consume less water than 
control mice (Fig. 7C).   
 
3.3. Administration of heat-killed echinostome metacercariae to mice treated with 1% DSS 
does not decrease induced intestinal distress but appears to exacerbate symptoms.  
The results of the initial trial revealed that 1% DSS, when given for 6 days, induces acute 
intestinal distress in C57BL/6 mice without causing excessive weight loss (four out of the five 
mice did not lose 25% of their body weight before 9 days), or highly bloody stools; therefore, 1% 
DSS was used in this phase of the project, which tested the effects of heat-killed echinostome 
metacercariae on mice treated with DSS.   
Thirty-two female, C57BL/6 mice, ages 6-8 weeks were identified and assigned 
treatment groups in the same method as the first two experiments.  Eight mice per treatment 
group were included to ensure proper controls were tested: Group 1 (DSS + Parasite), Group 2 
(Water + Parasite), Group 3 (DSS + PBS), and Group 4 (Water + PBS). (Table 5).   Mice in Groups 1 
and 3 were given 1% DSS dissolved in drinking water for 6 days, followed by regular water for 3 
days.  Mice in Groups 2 and 4 were given regular water for all 9 days.  DSS solutions/water were 
Treatment 
Group (n=5) 
# of mice that lost >25% body weight 
  Days 1-6 Day 7 Day 8 Day 9 
Control 0 0 0 0 
0.5% DSS 0 0 0 0 
1% DSS 0 0 1 2 
1.5% DSS 0 0 5 N/A 
 
Table 7.  Number of mice that lost over 25% of their initial 
body weight on each day during Experiment 2. 
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replaced every two days and average water consumption per mouse was calculated as 
previously described.  Average food consumption per mouse was calculated in the same method 
as water consumption.   
Thirty to forty echinostome metacercariae, dissected from infected snails and heat-
killed prior to the experiment, were orally administered on Day 3 to each mouse in Groups 1 and 
2.  PBS was orally administered on Day 3 to each mouse in Groups 3 and 4.  Weight, stool 
consistency, and presence of fecal blood (hema-screen) were recorded daily.  Mice were 
assigned an intestinal score from 0-4 as previously described in the first experiment (Table 3).  
On the ninth day, all mice were euthanized, and spleens and intestines were dissected.  
Intestines were stored in formalin for analysis of colon length.  To measure colon length, 
intestines were straightened and measured from the ileocecal junction to the rectum.  Spleens 
were disrupted and dissolved in a solution of 1 mL PBS with 0.1 mL 1.1% IPEGAL.  Splenic 
supernatants were kept at -20°C for analysis of pro-inflammatory cytokines IL-4 and IFN-γ, and 
regulatory cytokines IL-2 and IL-10 by ELISA. 
 Group 1 (DSS + Parasite) began testing positive for fecal blood on the first day and 
developed loose stools starting on the seventh day.  Mice in Group 1 had higher intestinal scores 
than mice in Group 2 (Water + Parasite) on the second day, and from the fourth to the ninth day 
(p≤0.0379) and higher scores than Group 4 (Water + PBS) from the second to the ninth day 
(p≤0.0049, 2-way ANOVA) (Fig. 8A).  Mice in Group 1 (DSS + Parasite) also lost more weight than 
mice in Group 2 (Water + Parasite) and Group 4 (Water + PBS) from the seventh to the ninth day 
(p≤0.046, 2-way ANOVA) (Fig. 8B).  Additionally, mice in Group 1 had higher intestinal scores and 
lost more weight than mice in Group 3 (DSS + PBS) on the ninth day (p≤0.02, 2-way ANOVA).   
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It was also revealed that mice in Group 1 (DSS + Parasite) did not consume less water 
than mice in Group 2 (Water + Parasite) or Group 4 (Water + PBS) but did consume less food 
than mice in Groups 2 and 4 on the eighth day (p<0.0001, 2-way ANOVA) (Fig. 8D).  Colon length 
analysis revealed that mice in Group 1 (DSS + Parasite) exhibited shorter colons after dissection 
then mice in Groups 2 and 4 (p≤0.0037, 1-way ANOVA) (Fig 9B.).  
 
Fig. 8.  The effects of heat-killed echinostome metacercariae on DSS-induced intestinal distress in C57BL/6 mice.  
Two groups of experimental mice were given 1% DSS dissolved in drinking water for 6 days, followed by regular 
water for 3 days.  Two groups of control mice were given regular water for all 9 days.  Eight mice per treatment 
group were included.  On Day 3, mice in Groups 1 and 2 were orally administered metacercariae and mice in 
Groups 3 and 4 were orally administered PBS.  For panels A, B, and D, group means, and standard deviations are 
plotted.  For panel C, each symbol represents one mouse.  (A) Stool consistency and presence of fecal blood 
(hema-screen) were used to provide an intestinal score of 0-4.  (B) Weight change during treatment, expressed as 
a percentage change from day 0.  (C) Correlation of intestinal score to weight change on each day for all mice.  
(D) Average food consumption per mouse was calculated by dividing the remaining volume in cages every two 
days by the number of mice per cage.  Statistical differences of groups (p<0.05) was determined using RM 2-way 
ANOVA matching: stacked with Tukey’s multiple comparisons.  Linear regression was used to determine R2 and p 
values for panel C. 
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Mice in Group 3 (DSS + PBS) began testing positive for fecal blood on the first day and 
developed loose stools starting on the seventh day.  Mice in Group 3 (DSS + PBS) had higher 
intestinal scores than mice in Group 4 (Water + PBS) from the fourth to the ninth day (p≤0.01), 
and higher scores than mice in Group 2 (Water + Parasite) from the sixth to the ninth day 
(p<0.0001, 2-way ANOVA) (Fig. 8A).  A linear equation was calculated for intestinal score from 
the fourth to sixth day (y=0.3750x-0.6042, linear regression) (Appendix 1D).  Mice in Group 3 
(DSS + PBS) lost more weight than mice in Groups 2 (Water + Parasite) and 4 (Water + PBS) on 
the eighth and the ninth days (p≤0.0187, 2-way ANOVA) (Fig. 8B).  
 
Fig. 9.  Average water consumption and colon lengths of mice treated with 1% DSS for 6 days and 
administered heat-killed metacercariae or PBS on Day 3.  For panels A-B, group means, and standard 
deviations are plotted.  (A) Average water consumption per mouse was calculated by dividing the remaining 
volume in cages every two days by the number of mice per cage (RM 2-way ANOVA, matching stacked with 
Tukey’s multiple comparisons test).  (B) Colon length was determined by straightening intestines and 
measuring the length from the ileocecal junction to the rectum (1-way ANOVA with Tukey’s multiple 
comparisons test).  (C) Correlation of average water consumption on Day 8 to average weight change on Day 
9 (linear regression).  (D) Correlation of average water consumption on Day 8 to average colon length (linear 
regression).     
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It was also revealed that mice in Group 3 (DSS + PBS) did not consume less water than 
mice in Groups 2 (Water + Parasite) and 4 (Water + PBS) (Fig. 9A) but did consume less food 
than mice in Groups 2 and 4 on the eighth day (p<0.0001, 2-way ANOVA) (Fig. 8D).  Colon length 
analysis revealed that mice in Group 3 (DSS + PBS) exhibited shorter colons after dissection then 
mice in Group 2 (Water + Parasite) and Group 4 (Water + PBS) (p≤0.0133, 1-way ANOVA) (Fig. 
9B).   
Mice in Group 2 (Water + Parasite) did not develop loose stools or progressive weight 
loss throughout the experiment (Fig. 8A, B).   However, two out of eight mice in Group 2 (Water 
+ Parasite) tested positive for fecal blood on the third day, one mouse on the fourth day, one 
mouse on the fifth day, and one mouse on the eighth day.   Mice in Group 2 showed no 
significant differences between mice in Group 4 (Water + PBS) for weight change, intestinal 
scores, colon length, water consumption, or food consumption.   
Mice in group 4 (Water + PBS) did not develop loose stools or progressive weight loss 
throughout the experiment (Fig. 8A, B).   
An overall correlation between weight change and intestinal score was observed for all 
mice throughout the experiment (p<0.0001, linear regression) (Fig. 8C).  This correlation was 
further revealed for mice in DSS treatment groups (Appendix 2A, B), but not for mice in 
untreated groups (Append. 2C, D).  A correlation between average water consumption on the 
eighth day and average weight change on the ninth day was observed (Fig. 9C), as well as a 
correlation between average water consumption on the eighth day and average colon length 
(Fig. 9D).    
The results of the initial trial showed no differences between identical groups in the first 
two experiments.  Mice receiving 1.5% DSS in the first experiment showed no differences in 
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weight change or water consumption throughout the experiment (Fig. 10A, B).  Furthermore, 
mice receiving water in the first experiment showed no difference in weight change or water 
consumption than mice receiving water in the second experiment (Fig. 10A, B).  However, our 
results revealed that mice receiving 1% DSS and PBS in the third experiment lost less weight 
than mice receiving 1% DSS in the second experiment from the sixth to the eighth day (p≤0.001, 
2-way ANOVA) (Fig. 10C).  The data also suggested that mice receiving water and PBS in the 
 
Fig. 10.  Analysis of weight change and water consumption between groups for all three experiments.  For all 
panels, group means, and standard deviations are plotted.  (A) Weight change, expressed as a percentage 
change from day 0, for mice receiving 1.5% DSS or water in the first two experiments.  (B) Average water 
consumption, measured by dividing the remaining volume every two days by the number of mice per cage, 
for mice receiving 1.5% DSS or water in the first two experiments.  (C) Weight change for mice receiving 1% 
DSS or water in experiments two and three.  (D)  Average water consumption for mice receiving 1% DSS or 
water in experiments two and three.  Statistical differences between groups (p<0.05) was determined using 
RM 2-way ANOVA matching: stacked with Tukey’s multiple comparisons. 
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third experiment gained less weight than mice receiving water in the second experiment on the 
eighth day (p=0.065, 2-way ANOVA) (Fig. 10C).   
The results of the second experiment revealed that mice receiving 1% DSS consumed 
less water on average than mice receiving water on the eighth day (p=0.0068, 2-way ANOVA) 
(Fig. 10D), however mice receiving 1% DSS and PBS in the third experiment did not consume 
significantly less water than mice receiving water and PBS in the third experiment (Fig. 10D).  
Furthermore, while mice receiving water in the second experiment consumed approximately the 
same amount of water on average throughout the experiment, mice receiving water and PBS in 
the third experiment consumed less water on the sixth and eight days (Fig. 10D).   
 
3.4. Mice treated with 1% DSS and administered heat-killed echinostome metacercariae 
showed decreased levels of regulatory cytokine IL-2 when compared to mice in all other groups. 
Spleens from individual mice were dissected on Day 9 and were disrupted and dissolved 
in a solution of 1 mL PBS and 0.1 mL 1.1% IPEGAL.  Supernatants were analyzed using a Mouse 
TH1/TH2 ELISA kit (Thermofisher Scientific). The detection ranges for each cytokine were 
reported by the manufacturer to be: IL-4, 4-500 pg/mL; IFN-γ, 15-2000 pg/mL; IL-2, 2-200 
pg/mL; and IL-10, 30-4000 pg/mL.  In all samples where the calculated cytokine concentration 
was at or below the given sensitivity, it was plotted as the lowest detectable concentration for 
that cytokine (Table 8). 
In order to detect levels of IL-2, a cytokine associated with TH1 cells and TREG cell 
differentiation, five or six mice per treatment group were analyzed on two ELISA plates.  We 
showed that detectable levels of IL-2 (≥2 pg/ml) were present in the spleens of four out of five 
tested mice in Group 1 (DSS + Parasite), all tested mice in Group 2 (Water + Parasite), all tested 
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mice in Group 3 (DSS + PBS), and all tested mice in Group 4 (Water + PBS) (Table 8, Fig. 11A).  
Statistical analysis revealed that mice in Group 1 (DSS + Parasite) had significantly lower levels of 
Table 8.  Splenic levels of regulatory cytokines IL-2 and IL-10, parasite specific cytokine IL-
4, and pro-inflammatory cytokine IFN-γ in mice treated with 1% DSS for 6 days and 
administered metacercariae or PBS on Day 3.  Splenic supernatants from each treatment 
group were analyzed by a mouse TH1/TH2 ELISA kit.  Mice not tested were recorded as n/t. 
 
Treatment Group Mice ID IL-2 IL-4 IL-10 IFN-γ 
 232 n/t n/t *0 *0 
 225 5.547 n/t *0 n/t 
 243 *0 n/t *0 n/t 
DSS + Parasite 245 n/t n/t 431.695 *0 
 248 6.362 *0 n/t *0 
 252 n/t *0 n/t n/t 
 254 3.028 *3.166 n/t n/t 
 256 2.729 n/t n/t n/t 
 233 4.835 n/t *0 n/t 
 226 4.812 n/t *0 n/t 
 236 13.588 n/t *0 *0 
Water + Parasite 237 4.792 n/t n/t n/t 
 240 n/t 7.44 n/t n/t 
 244 9.826 *0 n/t *0 
 246 8.768 9.566 n/t *0 
 247 8.619 *0 n/t *0 
 222 n/t n/t *0 n/t 
 224 4.806 n/t *9.032 n/t 
 229 9.491 n/t *0 *0 
DSS + PBS 235 n/t n/t *0 n/t 
 238 8.719 *0 n/t *0 
 242 8.954 *0 n/t *0 
 249 n/t *3.176 n/t n/t 
 251 6.907 n/t n/t *0 
 227 14.548 n/t 487.336 *0 
 228 8.164 n/t 105.517 n/t 
 234 15.018 n/t 43.214 n/t 
Water + PBS 239 21.767 n/t n/t 34.921 
 250 11.08 *0 n/t *0 
 253 n/t *0 n/t n/t 
 255 6.281 *0 n/t *0 
 257 n/t *0 n/t n/t 
 
* indicates concentration was below detectable level (IL-2=2 pg/ml, IL-4= 4 pg/ml, IL-10= 
30 pg/ml, IFN-γ= 15 pg/ml) 
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IL-2 than mice in Group 4 (Water + PBS) (p=0.0036, 1-way ANOVA) (Fig. 11A).   
Statistical analysis further revealed that mice in Group 1 (DSS + Parasite) had lower 
levels of IL-2 than mice in Group 2 (Water + Parasite) (p=0.026) (Fig. 12C), and mice in Group 3 
(DSS + Water) (p=0.0128, unpaired t test) (Fig. 12E). 
A correlation between IL-2 concentration and weight change on the ninth day 
(p=0.0345) (Fig. 12A), intestinal score on the ninth day (p=0.03) (Fig. 12B), and weight on the 
 
Fig. 11. Analysis of splenic cytokines in mice treated with 1% DSS for 6 days and administered 
metacercariae or PBS on Day 3.  Spleens were harvested after 9 days and supernatants were 
analyzed using ELISA.  For all panels, group means, and standard deviations are indicated, and each 
symbol represents one mouse.  (A) TH1, TREG cytokine IL-2.  (B) TH2 and parasite specific cytokine IL-4.  
(C) TH2, TREG cytokine IL-10.  (D) TH1 and pro-inflammatory cytokine IFN-γ.  Statistical differences of 
groups (p<0.05) was determined using 1-way ANOVA with Tukey’s multiple comparisons test. 
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ninth day (p=0.0232, linear regression) (Appendix 3A) was observed.  No correlation between IL-
2 concentration and initial weight was observed (Appendix 3B).   
 
Fig. 12.  Analysis of splenic cytokine IL-2 in mice treated with 1% DSS for 6 days and administered 
metacercariae or PBS on Day 3.  Spleens were harvested after 9 days and supernatants were analyzed for 
regulatory cytokine IL-2 (n=5-6 per treatment group) using ELISA.  For panels A and B, each symbol 
represents one mouse.  For panels C-F, group means, and standard deviations are plotted.  (A) Correlation 
of weight change on Day 9 and IL-2 concentration.  (B) Correlation of intestinal score on Day 9 and IL-2 
concentration.  (C) IL-2 concentrations in groups receiving parasites.  (D) IL-2 concentrations in groups 
receiving PBS.  (E) IL-2 concentrations in groups receiving DSS.  (F) IL-2 concentrations in groups receiving 
water.  For panels A and B, linear regression was used to determine R2 and p values.  Statistical differences 
between groups (p<0.05) (Panels C-F) was determined using unpaired t test with Welch’s correction. 
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In order to detect levels of IL-4, a cytokine associated with TH2 cells and parasite 
expulsion, three or four mice per treatment group were analyzed on one ELISA plate.  We 
showed that detectable levels of IL-4 (≥4 pg/ml) were not present in the spleens of mice in 
Group 1 (DSS + Parasite), Group 3 (DSS + PBS), or Group 4 (Water + PBS), and were present in 
the spleens of two out of four tested mice in Group 2 (Water + Parasite) (Table 8, Fig. 11B). 
In order to detect levels of IL-10, a cytokine associated with TH2, TREG, and BREG cells, 
three or four mice per treatment group were analyzed on one ELISA plate.  We showed that 
detectable levels of IL-10 (≥30 pg/ml) were not present in the spleens of mice in Group 2 (Water 
+ Parasite), or Group 3 (DSS + PBS), and were present in the spleen of one out of four tested 
mice in Group 1 (DSS + Parasite), and all tested mice in Group 4 (Water + PBS) (Table 8, Fig. 11C). 
In order to detect levels of IFN-γ, a cytokine associated with TH1 cells and autoimmunity, 
three or four mice per treatment group were analyzed on one ELISA plate.  We showed that 
detectable levels of IFN-γ (≥15 pg/ml) were not present in the spleens of mice in Group 1 (DSS + 
Parasite), Group 2 (Water + Parasite), or Group 3 (DSS + PBS), and were present in the spleen of 
one out of four tested mice in Group 4 (Water + PBS) (Table 8, Fig. 11D). 
 
 
4.  Discussion 
 
IBD is an autoimmune disease characterized by chronic intestinal inflammation and 
epithelial damage (1,2,5-9).  Epidemiological studies show an inverse relationship between the 
frequency of helminth worm infections and IBD (1,2,5,7,8,15).  IBD is common in industrialized 
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countries where human helminth parasite infections are relatively sparse, whereas helminth 
parasites, including species from Class Trematoda and Phylum Nematoda, are still common in 
tropical countries where IBD is scarce. (1,2,5,8,15).  Various studies have been conducted on 
mice models of IBD in which mice were protected from chemically induced colitis (DSS or TNBS) 
by a helminth infection, or an isolated helminth protein (galectin) delivered prior to inducing 
symptoms of colitis (1,2,8,9,15,16,20).  Parasite have been shown to release proteins that 
induce a shift in TH1 to TH2 profiles, inhibiting IFN-γ and effector T cells, and producing IL-4 and 
IL-10 (1-5,7-9,13,15,17-20).  IFN-γ is a pro-inflammatory TH1 cytokine associated with the chronic 
inflammation in autoimmune diseases such as IBD (1,6,9,15,16,20,22).  IL-4 is a TH2 cytokine 
associated with parasite expulsion in the initial phase of infection (1-3,5,7,15,17,18), and IL-10 is 
a TH2 and regulatory cytokine often associated with the protective effects of helminth parasites 
(1-3,5,7,11-13,15-18).  Furthermore, parasite proteins may induce regulatory mechanisms 
including the production of TREG cells, BREG cells, regulatory DCs and macrophages, and regulatory 
cytokines TGF-β, IL-10, and IL-2 (1-5,7-9,13,15-21).  IL-2 is a TH1 cytokine shown to induce TREG 
cells following an infection (21). 
We questioned whether noninfectious helminth parasites (heat-killed echinostome 
metacercariae) delivered orally to C57BL/6 mice after several days of treatment with DSS would 
decrease symptoms of DSS-induced colitis in mice.  We hypothesized that mice treated with DSS 
for 6 days and administered heat-killed metacercariae during DSS treatment would show less 
weight loss, improved intestinal health, longer colons after dissection, decreased levels of pro-
inflammatory cytokines IFN-γ or IL-4, and/or increased levels of regulatory cytokines IL-2 and IL-
10 when compared to mice treated with DSS and not administered metacercariae.   
In order to test our hypothesis, we first established an optimal model of DSS-induced 
colitis in female C57BL/6 mice by dissolving different concentrations of DSS (3%, 2.25%, 1.5%, 
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1%, and 0.5%) in drinking water for 6 days, followed by regular water for 3 days. The goal of the 
initial trial was to find an “mid-point” concentration of DSS that induces moderate intestinal 
distress in female C57BL/6 mice living in the MSU, Mankato vivarium.  Weight, stool consistency, 
and presence of fecal blood were recorded daily, and water consumption was recorded every 
two days.  If mice lost over 25% of their body weight at any time they were euthanized after 
data collection that day.  After 9 days all remaining mice were euthanized following data 
collection.   
In the initial trial we demonstrated that mice given 3%, 2.25%, or 1.5% DSS for 6 days 
developed highly bloody stools and/or excessive weight loss of >25% of their body weight.  Also, 
mice given 3%, 2.25%, 1.5%, and 1% DSS consumed less water on average than control mice.  
One possible reason that mice consumed less water is that DSS may be bitter tasting, which 
could condition mice to drink less.  Another reason is that mice may eventually become too sick 
to drink as much, leading to dehydration and an increase in symptoms.  We further 
demonstrated that mice given 1% DSS for 6 days developed loose stools that tested positive for 
fecal blood, and lost more weight than control mice, but <25% of their body weight, and that 
mice given 0.5% DSS developed soft stools which occasionally tested positive for fecal blood, but 
did not lose more weight than control mice.  From the results of the initial trial, we conclude 
that 1% DSS is the optimal concentration that induces moderate intestinal distress; therefore 1% 
DSS was chosen for the next phase of the study.   
During the next phase, mice were fed heat-killed echinostome metacercariae in an 
attempt to counteract symptoms of DSS-induced colitis.  Two groups of experimental mice 
received 1% DSS dissolved in drinking water for 6 days followed by regular water for 3 days, and 
two groups of control mice received regular water for all 9 days.  One group of experimental 
mice and one group of control mice were orally administered heat-killed metacercariae in PBS 
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on the third day of DSS treatment (DSS + Parasite, Water + Parasite).  The other two groups 
were orally administered PBS on the third day of DSS treatment (DSS + PBS, Water + PBS).  
Weight, stool consistency, and presence of fecal blood were recorded daily, and water and food 
consumption were recorded every two days.  After 9 days all mice were euthanized, and 
intestines and spleens were dissected.  Colon lengths were recorded for individual mice and 
spleens were disrupted and tested for inflammatory cytokine IFN-γ, parasite specific cytokine IL-
4, and regulatory cytokines IL-10 and IL-2, using ELISA.      
In this phase we demonstrated that mice administered heat-killed echinostome 
metacercariae during treatment with 1% DSS did not show a decrease in weight loss, improved 
intestinal health, or longer colons after dissection than mice treated with 1% DSS but not 
administered metacercariae.  Inversely, on the ninth day of the experiment, mice administered 
metacercariae during DSS treatment weighed significantly less and had poorer intestinal health 
than mice treated with DSS but not administered metacercariae, suggesting that heat-killed 
metacercariae may exacerbate symptoms of colitis in DSS treated mice.  Analysis of splenic 
cytokines showed that mice treated with DSS and administered metacercariae had lower levels 
of regulatory cytokine IL-2 than mice treated with DSS but not administered metacercariae.   
It was also noted that mice receiving 1% DSS in the second experiment lost more weight 
than mice receiving 1% DSS in their drinking water and gavaged with PBS in the third 
experiment, and that control mice receiving water in the second experiment gained more 
weight than mice drinking water and gavaged with PBS in the third experiment.  The data also 
demonstrated that control mice receiving water in the second experiment drank more water 
than mice drinking water and gavaged with PBS in the third experiment. 
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Since there was little variation between the first and second experiments (mice 
receiving 1.5% DSS or control mice in the first experiment did not show statistical differences 
between weight change or water consumption compared to mice receiving 1.5% DSS or control 
mice in the second experiment), this was a surprising result.  It is possible that gavaging mice 
affects the amount of water consumption and therefore weight change.  If this experiment were 
to be repeated, mice should also be gavaged during the initial trial when determining the 
optimal level of DSS.   
A significant correlation between weight change and intestinal score was observed in 
mice treated with DSS, demonstrating that increased weight loss is associated with poorer 
intestinal health.  This was expected since DSS induces symptoms of both weight loss and 
intestinal distress in mice (16,20,22,23).  We also demonstrated that mice treated with DSS 
exhibited shorter colons after dissection than mice that did not receive DSS, regardless of 
parasite treatment.  This result was expected since mice treated with DSS have been previously 
shown to exhibit shorter colons (16,20).  A correlation between average colon length and 
average water consumption on Day 8 was observed, demonstrating that less water consumption 
is associated with shorter colons.  Since mice treated with DSS consume less water it is possible 
that dehydration is what causes the shortening of colons.  A correlation between weight change 
on Day 9 and average water consumption on Day 8 was also observed, demonstrating that less 
water consumption contributes to more weight loss.   
Previous literature describing the effects of parasites on mice models of colitis described 
a shift in T cell subsets leading to a decrease in inflammatory cytokines and an increase in 
regulatory cytokines (16).  In this study we demonstrated that mice administered metacercariae 
during DSS treatment showed lower levels of the regulatory cytokine IL-2 than mice in all other 
groups.  A correlation between IL-2 concentrations and weight change, intestinal score, and 
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weight on the ninth day was observed, demonstrating that lower IL-2 levels are associated with 
increased symptoms of colitis.  We did not observe a correlation between IL-2 concentration 
and initial weight, confirming that IL-2 levels analyzed in this study are not dependent on mouse 
weight, but rather on intestinal health.  
 Since previous literature describing the effects of parasites on DSS-induced colitis in 
mice did not analyze IL-2, we questioned the role of IL-2 in mice treated with DSS and 
administered heat-killed metacercariae.  We confirmed that a decrease in IL-2 levels was driven 
by both DSS treatment and parasite administration.  The DSS model induces a shift in T cell 
subsets, leading to an increase in TH1 cells and pro-inflammatory cytokines.  Because of this we 
would expect to see lower levels of regulatory cytokines during symptoms of colitis.  IL-2 is 
thought to induce TREG cells at the end of an infection.  The data showed that mice treated with 
DSS but not administered parasites exhibited intestinal distress while treated with DSS but 
showed a decrease in symptoms once regular water was given, suggesting that IL-2 was 
produced once DSS was no longer administered, leading to remission in mice. 
Mice treated with DSS and administered parasites continued to exhibit intestinal 
distress once regular water was given.  The data also showed that mice not treated with DSS but 
administered parasites exhibited acute intestinal distress on the third day, several hours after 
metacercariae were orally administered.  Cytokine analysis revealed that mice receiving parasite 
treatment but not DSS showed detectable levels of IL-4 (although it is noted that only a small 
sample size was tested for this cytokine.)  In the initial stage of a parasite infection, a pro-
inflammatory response and the production of cytokine IL-4 is induced, which allows the body to 
expel the parasites, while the long-term phase of a parasite infection induces a regulatory 
response.  It is possible that a single dose of heat-killed metacercariae fed to mice initiates or 
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prolongs a pro-inflammatory immune response and may block the production of regulatory 
cytokine IL-2 in DSS-treated mice once DSS is no longer administered.  
Detectable levels of the regulatory cytokine IL-10 were present in the spleens of all 
tested mice not treated with DSS or administered parasites, and in one tested mouse treated 
with DSS and administered parasites.  Detectable levels of the pro-inflammatory cytokine IFN-γ 
were only present in tested mice not treated with DSS or administered parasites.  It is noted that 
only a small sample size was tested for both IL-10 and IFN-γ.  Because of faulty reagents or 
equipment, only one ELISA plate was conclusive for each cytokine.  Because of this, three or four 
mice per treatment group were analyzed for IFN-γ, IL-4, and IL-10.  If this experiment were to be 
repeated it may be necessary to measure fewer cytokines in order to have more replicates.   
In this study we also demonstrated that mice treated with 1% DSS consumed less food 
on average then mice not treated with DSS, suggesting that as mice become sick, they are 
unable to eat as much.   Because food consumption was not measured during the initial trial, it 
is possible that a lack of nutrients, as well as dehydration, contributes to weight loss in mice 
models of colitis.   
Previous literature describing the effects of parasites in mice models of colitis reported 
inducing a parasite stimulus before treatment with DSS and demonstrated a protective response 
of parasites against DSS-induced colitis (1-3,5,7-9,15,16,20).  Also, previous literature reported 
inducing a long-term parasite stimulus, via a live infection, or multiple injections with galectin.  It 
is unknown if non-living, whole parasites can be used as a form of treatment in mice models of 
colitis.  Because the parasites in this study were noninfectious and delivered while symptoms of 
colitis were present, they most likely passed through the digestive tract.  During the clinical 
phase of colitis, nutrients and water are less likely to be absorbed through the intestinal tract.  It 
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is possible that heat-killed metacercariae delivered during DSS treatment do not remain inside 
of the body long enough to induce a regulatory immune response and decrease symptoms of 
colitis.   
If this experiment were to be continued, multiple doses of metacercariae may be 
needed to stimulate the immune system into forming a regulatory response.  This could be done 
by obtaining more infected snails and feeding metacercariae to mice on multiple days.  Also, the 
metacercariae may need to be administered during a period of remission, so that they remain 
inside of the body long enough to induce a regulatory immune response.  This is could be done 
by expanding the experiment to 18 days and administering metacercariae in between treatment 
with DSS.   
Based on the data we conclude that heat-killed metacercariae administered to female 
C57BL/6 mice during treatment with 1% DSS do not protect mice from DSS-induced symptoms 
of colitis but appear to exacerbate symptoms, possibly by blocking regulatory IL-2 production 
once DSS administration is stopped.  Furthermore, a single dose of metacercariae may not be 
sufficient to alter the immune symptom to favor a regulatory response, and multiple doses 
given throughout DSS treatment or during periods of remission may be required.  Further 
studies are necessary to determine whether delivering non-infectious whole parasites as a 
treatment method can stimulate the immune system to form a regulatory response, thus 
reducing chronic inflammation and relieving symptoms of autoimmunity.  
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Appendix 1.  Linear equations of intestinal distress for mice treated with 1.5% DSS or 1% DSS for all 
experiments.  Intestinal scores increase at a significant rate from the fourth to sixth day when mice 
are treated with 1% DSS or 1.5% DSS for 6 days.  For panels A-C, five mice were included, and for 
panel D, eight mice were included.  (A) Mice receiving 1.5% DSS during experiment 1.  (B) Mice 
receiving 1.5% DSS during experiment 2.  (C) Mice receiving 1% DSS during experiment 2.  (D) Mice 
receiving 1% DSS during experiment 3.  Linear regression was used to determine line equations and 
R2 values.   
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Appendix 2.  Correlation of weight change and intestinal score for mice treated with 1% DSS for 6 
days and administered metacercariae or PBS on day 3.  For all panels, correlation of weight change, 
expressed as a percentage change from day 0, to intestinal score (0-4) are graphed for individual 
mice (n=8 per group).  (A) DSS and parasite treatment.  (B) DSS treatment and PBS.  (C) Water and 
parasite treatment.  (D) Water and PBS.  Linear regression was used to determine R2 and p values.   
 
48 
 
 
  
 
Appendix 3.  Correlations of splenic cytokines and weight, weight change, or intestinal score on Day 9 
in mice treated with 1% DSS and administered metacercariae or PBS on Day 3.  Spleens were 
harvested after 9 days and supernatants were tested for regulatory cytokines IL-2 and IL-10, parasite 
specific cytokine IL-4, and pro-inflammatory cytokine IFN-γ using ELISA.  For all panels, each symbol 
represents one mouse. (A) Weight on Day 9 and IL-2 concentration.  (B) Weight on Day 0 and IL-2 
concentration.  (C) Weight change on Day 9, expressed as a percentage change from Day 0, and IL-4 
concentration.  (D) Intestinal score on Day 9 and IL-4 concentration.  Linear regression was used to 
determine R2 and p values.   
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Appendix 3 (continued).  Correlations of splenic cytokines and weight change or intestinal score on 
Day 9 in mice treated with 1% DSS and administered metacercariae or PBS on Day 3.  For all panels, 
each symbol represents one mouse. (E) Weight change on Day 9 and IL-10 concentration.  (F) 
Intestinal score on Day 9 and IL-10 concentration.  (G) Weight change on Day 9 and IFN-γ 
concentration.  (H) Intestinal score on Day 9 and IFN-γ concentration.  Linear regression was used to 
determine R2 and p values.   
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Appendix 4.  Weight change and intestinal scores for individual mice treated with 1% DSS for 6 
days and administered heat-killed metacercariae or PBS on Day 3.  For left panels, weight change, 
expressed as a percentage change from day 0, are graphed for individual mice (n=8 per group).  
For right panels, intestinal scores (0-4) are graphed for individual mice (n=8 per group).  Panels A-
B: DSS and parasite treatment.  Panels C-D:  DSS treatment and PBS.   
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Appendix 4 (continued).  Weight change and intestinal scores for individual mice treated with 
1% DSS for 6 days and administered heat-killed metacercariae or PBS on Day 3.  For left panels, 
weight change, expressed as a percentage change from day 0, are graphed for individual mice 
(n=8 per group).  For right panels, intestinal scores (0-4) are graphed for individual mice (n=8 per 
group).  Panels E-F: Water and parasite treatment.  Panels G-H: Water and PBS. 
 
 
